OVERVIEW

Recognizing and Treating Venous Thromboembolism (VTE) in Patients with Cancer - Bridging Guideline-Based Recommendations with Real-World Evidence is organized by Physicians' Education Resource, LLC (PER).

Release Date: February 27, 2020
Expiration Date: February 27, 2021

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Overview:
As cancer incidence rates remain high, so does the risk of disease- or treatment-related complications, such as venous thromboembolism (VTE), leading to devastating functional losses and even death. In fact, VTE, comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs 4- to 7-fold higher in patients with cancer compared with the general population. Because several different types of cancer are associated with a higher risk of clot formation, management of VTE requires a multidisciplinary approach to treatment and prophylaxis. It is imperative for oncologists and hematologists to have knowledge of VTE risk factors and stratification, management strategies using low-molecular weight heparins or direct oral anticoagulants, guideline-based recommendations for care, and methods for reducing recurrence following initial treatment.

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Recognize the prevalence, morbidity, and mortality rates as well as risk factors associated with development of VTE in patients with cancer.
• Apply recent evidence-based guideline recommendations for the prevention and treatment of cancer-associated VTE into clinical practice.
• Identify strategies for the prevention and treatment of VTE in patients with cancer, including the reduction of risk of recurrence following initial treatment.
• Implement individualized anticoagulation regimens for prevention and treatment of VTE in patients with cancer that are based on the unique needs and characteristics of each patient.